Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Long-Term Investments (2024 - 2026)

Translational Development Acquisition's Long-Term Investments history spans 3 years, with the latest figure at $183.3 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments rose 4.02% to $183.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $183.3 million, a 4.02% increase, with the full-year FY2025 number at $181.7 million, up 4.19% from a year prior.
  • Long-Term Investments came in at $183.3 million for Q1 2026, up from $181.7 million in the prior quarter.
  • The five-year high for Long-Term Investments was $183.3 million in Q1 2026, with the low at $174.4 million in Q4 2024.
  • Historically, Long-Term Investments has averaged $178.9 million across 3 years, with a median of $179.0 million in 2025.
  • Biggest five-year swings in Long-Term Investments: increased 4.19% in 2025 and later rose 4.02% in 2026.
  • Year by year, Long-Term Investments stood at $174.4 million in 2024, then increased by 4.19% to $181.7 million in 2025, then increased by 0.89% to $183.3 million in 2026.
  • Business Quant data shows Long-Term Investments for TDAC at $183.3 million in Q1 2026, $181.7 million in Q4 2025, and $179.9 million in Q3 2025.